Literature DB >> 19001773

Effects of genistein on oxidative injury in endothelial cells.

Guowei Huang1, Yinghua Liu, Hong Chang, Xumei Zhang, Dalin Ren, John X Wilson, Xiaohong Cao.   

Abstract

The aim of this study was to test the hypothesis that genistein protects vascular endothelial cells against the pro-atherosclerotic stressor, oxidized low-density lipoprotein (ox-LDL), by inducing antioxidant enzymes and preventing apoptosis. Human umbilical cord-derived endothelial cells (ECV 304) were incubated with genistein (10-100 micromol/L), the radical scavenging antioxidant vitamin E (alpha-tocopherol, 50 micromol/L), or vehicle for 24 h and then were incubated with ox-LDL for an additional 24 h. Subsequently, antioxidant enzyme activities, lipid peroxidation, adhesion to monocytes, cell morphology, viability and apoptotic index were assessed. Ox-LDL decreased superoxide dismutase and glutathione peroxidase activities in endothelial cells and caused lipid peroxidation, adhesion to monocytes, morphological injury and apoptosis (p<0.05). These effects were prevented by vitamin E and dose-dependently by genistein (p<0.05). Further, this effect of genistein is associated with maintenance of antioxidant enzyme activities and inhibition of lipid peroxidation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19001773     DOI: 10.3177/jnsv.54.402

Source DB:  PubMed          Journal:  J Nutr Sci Vitaminol (Tokyo)        ISSN: 0301-4800            Impact factor:   2.000


  2 in total

1.  Protective effects of 7-difluoromethyl-5,4'-dimethoxygenistein against human aorta endothelial injury caused by lysophosphatidyl choline.

Authors:  Fei Liu; Jian-Guo Cao; Cheng Li; Jin-Seng Tan; Xiao-Hua Fu
Journal:  Mol Cell Biochem       Date:  2011-12-24       Impact factor: 3.396

2.  Soy milk consumption, inflammation, coagulation, and oxidative stress among type 2 diabetic patients with nephropathy.

Authors:  Maryam Sadat Miraghajani; Ahmad Esmaillzadeh; Mojgan Mortazavi Najafabadi; Maryam Mirlohi; Leila Azadbakht
Journal:  Diabetes Care       Date:  2012-07-11       Impact factor: 19.112

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.